Key result
Dyslipidemia and metabolic syndrome contribute to cardiovascular damage through multiple cellular and molecular pathways, such as oxidative stress and inflammation, providing novel targets for disease prevention and treatment.
Answers are grounded in this paper and cite their sources.
This special issue collection highlights novel pathogenic pathways and potential therapeutic mechanisms linking dysmetabolic conditions to cardiovascular and vascular dysfunction.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Chimenti et al. (2024) conducted an editorial in Dyslipidemia and metabolic syndrome. Dyslipidemia and metabolic syndrome was evaluated. Dyslipidemia and metabolic syndrome contribute to cardiovascular damage through multiple cellular and molecular pathways, such as oxidative stress and inflammation, providing novel targets for disease prevention and treatment.
Synapse has enriched 10 related papers. Consider them for comparative context: